Over 1000 Orphan Drugs in Clinical Trials in the US - Eylea, Actimmune, Ravicti Among Key Approved Therapies
August 07, 2023 06:43 ET
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
ODW Logistics Joins Pelotonia’s Celebration of 15 Years of One Goal for Cancer Research and Funding
August 03, 2023 09:21 ET
|
ODW Logistics
COLUMBUS, Ohio, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ODW Logistics, a fast-growing national third-party (3PL) specializing in integrated logistics solutions today announced the company’s support of...
AI in Oncology Market Report 2023-2033: Accelerated Drug Discovery and Targeted Therapies Driving Growth
July 21, 2023 06:13 ET
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Oncology Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global revenue for...
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering
July 21, 2023 02:15 ET
|
Turnstone Biologics Corp.
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing new medicines to treat and cure...
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
July 05, 2023 08:00 ET
|
F-star Therapeutics, Inc.
LONDON, July 05, 2023 (GLOBE NEWSWIRE) -- F-star Therapeutics, an invoX company (“F-star”), today announced that it has entered into a strategic discovery collaboration and licence agreement with...
Advancements in Multiomics: Automation of Opal Staining on NanoVIP Saves 80% Reagent Cost and 90% Hands-on Time
May 22, 2023 11:58 ET
|
BioGenex
Fremont, California, May 22, 2023 (GLOBE NEWSWIRE) -- Omicsveu has achieved a milestone with its NanoVIP instrument – a slide-based automated staining system - fully automating the Opal manual...
Weichert’s Charity Outing Tees Off in August
May 19, 2023 06:10 ET
|
Weichert Companies
Morris Plains, NJ, May 19, 2023 (GLOBE NEWSWIRE) -- Weichert, Realtors will host its 23rd Annual Charity Outing on Thursday, Aug. 17, at Fiddler’s Elbow Country Club in Bedminster, NJ. The event,...
PDS Biotech to Present Updated Data at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Highlighting Combination of PDS0101 and KEYTRUDA® (pembrolizumab) in Head and Neck Cancer Patients
April 27, 2023 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 27, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Purdue Research Foundation monetizes Pluvicto royalty interests to fund further research at Purdue University
April 26, 2023 08:00 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind. and NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Purdue Research Foundation, a private not-for-profit institute to advance the research of Purdue University, has received more...
PDS Biotech Receives $1.4 Million After Selling Its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Program
April 24, 2023 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., April 24, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...